EV-304
Padcev-Keytruda Combination Succeeds Again in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
Padcev; Keytruda; bladder cancer; KEYNOTE-B15; EV-304; event-free survival
Actionable Insights Powered by AI
Padcev; Keytruda; bladder cancer; KEYNOTE-B15; EV-304; event-free survival